Bloom Energy Shares Surge on 26 Billion AI Infrastructure Deal with Nebius General Motors Unveils AllElectric Cadillac Vistiq with 300Mile Range Burberry Shares Surge on Report of Potential Moncler Bid Jim Cramers Latest Take on Costco Wholesale What It Signals for Investors Chinas DeepSeek Challenges AI Cost Paradigm with LowChip Strategy Delays and Border Check Suspension at Dover Disrupt Holiday Travel Impacting Ferry Operators and Tourism Sector Two Harbors TWOD Q1 2026 Earnings EPS Surges Past Estimates as Interest Rate Environment Supports Mortgage REIT Performance FITB Q1 2026 Earnings Strong EPS Surprise of 35 Powered by Core Operations HRI Q1 2026 Earnings Strong EPS Beat Surprises Market Keurig Dr Pepper KDP Q1 2026 Earnings EPS Surpasses Estimates with 375 Beat Maison Solutions Inc MSS Q1 2026 Earnings Significant Earnings Miss Raises Concerns MRCY Q1 2026 Earnings Massive EPS Surprise of 284 Drives Stock Higher Onto Innovation ONTO Dips 266 as Support at 25355 Comes into Focus Janus Living Inc JAN Shows Modest Uptick as Stock Trades Near MidRange Tuniu TOUR Stock Nears Support After Modest Decline Ellington Financial EFC Slips Slightly as Stock Nears Key Support Gildan Activewear GIL Gains Ground as Stock Climbs Toward Key Resistance Asbestos Found in UK Childrens Toys Regulatory Gaps Could Impact Toy Retailers and Importers RAVE Q3 2024 Earnings Positive EPS Amid Limited Visibility Stock Declines Edgewise Therapeutics EWTX Holds Steady Near Support as Consolidation Continues TaskUs Q1 2026 Earnings EPS Slightly Misses Estimates Stock Rises Shoulder Innovations Inc SI Q1 2026 Earnings Narrower Loss Beats Estimates Despite Revenue Uncertainty ASB Q1 2026 Earnings EPS Beats Estimates Stock Slightly Lower Worthington Enterprises Q1 2026 Earnings EPS Beats Estimates Amid Operational Strength Standard Motor Products SMP Q1 2026 Earnings EPS Surpasses Estimates by 678 Despite Unreported Revenue MGEE Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Performance TCRT Q4 2023 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports No Revenue